Log in

NASDAQ:SUPNSupernus Pharmaceuticals Earnings Date, Estimates & History

$23.86
-0.26 (-1.08 %)
(As of 06/1/2020 04:00 PM ET)
Add
Compare
Today's Range
$23.84
Now: $23.86▼
$24.57
50-Day Range
$17.65
MA: $21.93▼
$24.50
52-Week Range
$13.12
Now: $23.86▼
$34.11
Volume538,902 shs
Average Volume603,859 shs
Market Capitalization$1.25 billion
P/E Ratio11.00
Dividend YieldN/A
Beta1.59

Earnings

Supernus Pharmaceuticals (NASDAQ:SUPN) Earnings Information

Supernus Pharmaceuticals last announced its earnings results on May 5th, 2020. The specialty pharmaceutical company reported $0.40 EPS for the quarter, topping analysts' consensus estimates of $0.30 by $0.10. The business earned $94.98 million during the quarter, compared to the consensus estimate of $84.01 million. Its revenue was up 11.1% compared to the same quarter last year. Supernus Pharmaceuticals has generated $2.10 earnings per share over the last year and currently has a price-to-earnings ratio of 11.0. Supernus Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 4th, 2020 based off prior year's report dates.

Supernus Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Supernus Pharmaceuticals (NASDAQ:SUPN) Earnings Estimates

2020 EPS Consensus Estimate: $1.50
2021 EPS Consensus Estimate: $1.66
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20203$0.21$0.27$0.24
Q2 20203$0.24$0.50$0.36
Q3 20203$0.35$0.49$0.42
Q4 20202$0.41$0.56$0.49
Q1 20212$0.26$0.40$0.33
Q2 20212$0.38$0.45$0.42
Q3 20212$0.45$0.46$0.46
Q4 20211$0.46$0.46$0.46

Supernus Pharmaceuticals (NASDAQ SUPN) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/4/2020
(Estimated)		       
5/5/20203/31/2020$0.30$0.40$0.40$84.01 million$94.98 millionTranscript
2/25/2020Q4 2019$0.57$0.62$0.62$107.27 million$100.45 millionTranscript
11/5/2019Q3$0.59$0.54$0.54$108.70 million$102.14 millionTranscript
8/6/2019Q2 2019$0.56$0.6070$0.61$109.67 million$104.70 millionListen
5/7/20193/31/2019$0.44$0.34$0.34$102.26 million$85.50 millionN/A
2/26/2019Q4 2018$0.27$0.48$0.48$105.36 million$113.50 millionListen
11/6/20189/30/2018$0.43$0.52$0.52$100.75 million$102.99 millionListen
8/7/2018Q2 2018$0.43$0.57$0.57$101.01 million$99.54 millionN/A
5/8/2018Q1 2018$0.33$0.49$0.49$85.26 million$90.43 millionN/A
2/27/2018Q4 2017$0.26$0.44$0.62$87.84 million$88.44 millionN/A
11/6/2017Q3 2017$0.27$0.29$0.29$78.74 million$80.40 millionN/A
8/2/2017Q2 2017$0.24$0.32$0.32$68.54 million$75.83 millionListen
5/9/2017Q1 2017$0.22$0.19$0.19$57.91 million$57.58 millionListen
2/28/2017Q4 2016$0.24$0.26$0.26$58.87 million$62.37 millionN/A
1/20/2017Q3 2016$0.37($0.44)$56.23 million$56.81 millionN/A
8/2/2016Q2 2016$0.13$0.18$0.18$49.67 million$50.40 millionListen
5/3/2016Q1 2016$0.08$0.08$0.08$45.33 million$43.00 millionListen
3/2/2016Q4 2015$0.06$0.14$0.14$42.93 million$42.70 millionListen
11/3/2015Q3 2015$0.02$0.08$0.08$37.93 million$38.60 millionListen
8/4/2015Q2 2015$0.02$0.03$0.03$34.07 million$35.10 millionListen
5/5/2015Q1 2015$0.02$0.05$0.08$29.16 million$28.13 millionListen
3/10/2015Q4 2014($0.05)$0.08$0.06$26.37 million$30.80 millionN/A
11/11/2014Q3 2014$0.45($0.20)($0.79)$43.10 million$52.50 millionN/A
8/11/2014Q2 2014($0.18)$0.06$0.04$19.85 million$29.67 millionN/A
5/12/2014Q1 2014($0.44)($0.36)($0.34)$9.94 million$9.00 millionN/A
3/12/2014Q4 2013($0.54)($0.39)($0.13)$7.78 million$10.30 millionN/A
11/12/2013Q3 2013($0.66)($0.65)($0.52)$2.54 million$1.26 millionListen
8/13/2013Q2 2013($0.67)($0.57)($0.25)$0.91 million$0.28 millionN/A
5/13/2013Q1 2013($0.63)($0.60)($0.60)$0.57 million$0.15 millionN/A
3/14/2013Q4 2012($0.73)($0.51)($0.51)N/A
11/7/2012Q312($0.62)($0.55)N/A
8/10/2012Q2 2012($0.48)($0.61)($0.61)N/A
6/7/2012Q1 2012($2.06)($6.05)($6.05)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 6/2/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.